Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them is Pfizer; in September that company announced it would acquire Metsera, a ...

Type 1 diabetes is an autoimmune disease (typically arising in younger people) that occurs when your immune system attacks ...

Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy are holding back sales at the pharma ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However, access ...

Walmart will offer in‑store pickup of Eli Lilly’s discounted weight‑loss drug Zepbound, giving self‑pay customers easier, ...

The specialty grocer is seeking to “recover for the losses it has suffered” at the hands of the “illegal Insulin Pricing ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

NEW YORK, NEW YORK - JULY 23: Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024, in New York City. In the U.S. drug market, higher list prices can paradoxically ...

President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through so-called “Most Favored Nation” pricing. The move comes after the ...